SEATTLE, July 22, 2021, (MEDGADGET) — Global Nerve Biologic Products Market Analysis
Overview
Artificial neural conduits, nerve grafts, nerve wraps, and nerve capping devices are examples of neural biologic products used to guide axonal outgrowth and aid nerve regeneration. These devices are primarily utilized in the treatment of nerve damage in clinical settings. Complex suturing, such as suturing two ends of a split nerve that requires a stiff procedure, is typically done with nerve biologic products. The scaffold material employed in the production of nerve biologic products is either synthetic or biological. Alginate, spider silk fiber, aragonite, chitosan, silkworm silk fibroin, collagen type I/III, and PSA (Polysialic acid) are among the biocompatible materials used to make nerve biologic products.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2265
Drivers
The global nerve biologic products market is forecast to grow due to advancements in research and development for creating revolutionary technologies for nerve biologic products. In February 2015, University of Sheffield engineers invented a device called 3D-printed NGC (nerve guiding conduit). The NGC (Nerve Growth Complex) is a network of tiny tubes that move wounded nerve endings towards each other, allowing them to heal spontaneously. The gadget is designed using CAD (computer-aided design), and it may be customized to fit any sort of nerve injury or even patient-specific nerves.
In addition, Polyganics, a medical device manufacturer, got the CE mark for Neurocap, a nerve capping device, in June 2016. Neurocap is an absorbable device that is used to treat and reduce symptomatic neuromas in the peripheral nerves. In January 2016, the gadget was approved for sale in the U.S.
Furthermore, certifications for nerve biologic products by the U.S. Food and Drug Administration (USFDA) are expected to boost growth of the global nerve biologic products market. Collagen Matrix Inc. got USFDA approval for their Flexible Collagen Nerve Conduit in June 2014. Flexible Collagen Nerve Conduit is a type I collagen tubular matrix that is restorable and flexible and provides encasement for peripheral nerve damage as well as shiatsu.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2265
AxoGen, Inc. also gained USFDA approval to continue with an IND (Investigational New Drug) application for Avance Nerve Graft in May 2015. Due to the USFDA’s enforcement discretion award, the medicine is commercially available while it is being transformed to a biologic product. It contains porcine submucosa extracellular matrix, which is utilized to cover and preserve damaged peripheral nerves, improve nerve restoration, and avoid soft tissue adhesion.
Restraints
The nerve biologic products market is estimated to be restrained by the USFDA’s product recalls owing to contamination and sterility difficulties. The USFDA recalled Integra LifeSciences’ NeuraWrap Nerve Protector and Dural Graft Matrix in June 2015 owing to a manufacturing process variation and greater quantities of pyrogens than allowed by the product’s criteria. Dural Graft Matrix was a soluble implant for the healing of dural defects, whereas NeuraWrap Nerve Protector was designed for the management of peripheral nerve damage.
Regional Insights
North America is projected to dominate the global nerve biologic products market over the forecast period, owing to an increase in the number of peripheral nerve injuries in the U.S. As per a study published in June 2017 by the Proceedings of the National Academy of Sciences of the U.S., over 250,000 people in the U.S. suffer from peripheral nerve injury each year.
The global nerve biologic products market is also projected to increase significantly in the Asia Pacific and Europe regions. This is due to an increase in public knowledge of central nervous system illnesses and therapeutic treatments as a result of planned conferences. The seventh International Conference on CNS (Central Nervous System) Disorder and Treatments will be conducted in Japan in June 2019, after the sixth International Conference on CNS Disorder and Therapeutics, which will be hosted in Paris in November 2018. The major themes discussed at these events include CNS illnesses and disorders, neuroimmunological disorders, neurometabolic disorders, brain tumors, and neurosurgery.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2265
Competitive Landscape
Major companies contributing in the global nerve biologic products market are Collagen Matrix, Inc., AxoGen, Inc., Checkpoint Surgical Inc., Stryker, TEXAS PHARMACUETICAL PVT LTD., Integra LifeSciences, and Polyganics.
Table of Content
Global Nerve Biologic Products Market Research Report
Section 1: Global Nerve Biologic Products Industry Overview
Section 2: Global Economic Impact on Nerve Biologic Products Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Nerve Biologic Products Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Nerve Biologic Products Market Forecast
Other Related Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837